Clinical Research

Clinical Trials Drug Efficacy Psychedelic Research Drug Development Drug Trials Randomized Controlled Trials Efficacy Studies Systematic Reviews Epidemiology Drug Studies

FDA Approves Eli Lilly’s Once‑Weekly Basal Insulin Onswik

It widens options for adults with type 2 diabetes by cutting injection burden after phase 3 data showed similar A1C control to daily insulins.

FDA to Convene Advisory Panel to Review Grail’s Galleri Cancer Screening Test

Psilocybin Therapy Puts Most Veterans With Treatment‑Resistant PTSD Into Remission

FDA Approves Xocova as First U.S. Post-Exposure COVID-19 Antiviral

Semaglutide Patents Lapse in India and China as Safety Scrutiny Rises

FDA Approves Teclistamab–Daratumumab Combination for Relapsed Multiple Myeloma After One Prior Therapy

FDA Grants Priority Review to Otsuka’s ADHD Drug Centanafadine With July 24 Decision Date

AstraZeneca Withdraws Andexxa From U.S. Market After FDA Says Risks Outweigh Benefits

Smartwatch Alerts Halve Severe Tantrums in Mayo Clinic Randomized Trial

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

Single Psilocybin Dose Plus Mindfulness Eases Depression for Frontline Clinicians in Randomized Trial

NMC Clears 10,650 MBBS Seats and 41 New Colleges, Taking India’s Total to 137,600

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

App-Based Relaxation Nearly Doubles Rate of Disability Improvement for ED Migraine Patients

MHRA Reforms and AI Cut UK Clinical Trial Approval Times to 41 Days

Mayo Clinic Launches Platform_Orchestrate as a Single Front Door for Faster Clinical Development

FDA Authorizes Essilor’s Stellest Lens, First U.S. Spectacle Lens Shown to Slow Childhood Myopia

FDA Launches New Safety Review of Abortion Pill Mifepristone

FDA Opens Door to Reconsider Capricor’s Duchenne Cell Therapy Based on HOPE-3 Data

Green-Mediterranean Diet Tied to Slower Brain Aging Markers in 18-Month Trial